Delphi Private Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-132
Closed -$10K 212
2016
Q4
$10K Sell
132
-67
-34% -$4.99K 0.02% 100
2016
Q3
$16K Sell
199
-83
-29% -$6.64K 0.03% 76
2016
Q2
$22K Buy
282
+18
+7% +$1.35K 0.04% 80
2016
Q1
$19K Sell
264
-18
-6% -$1.36K 0.03% 98
2015
Q4
$24K Buy
+282
New +$23.4K 0.04% 92

Other funds holding LLY

Delphi Private Advisors's LLY Position: Q1 2017 in Review

Delphi Private Advisors sold out of Eli Lilly (LLY) in Q1 2017, closing a stake of 132 shares — an estimated $10K sold.

Delphi Private Advisors first reported a position in LLY in Q4 2015 and held it in 5 quarters. The position peaked at $24K in Q4 2015. 1,249 funds tracked by Wall St. Rank hold LLY as of Q1 2017.

  • Delphi Private Advisors reported no remaining Eli Lilly position as of Q1 2017 after selling out during the quarter.
  • Delphi Private Advisors sold 132 Eli Lilly shares in Q1 2017, an estimated $10K.
  • Delphi Private Advisors first reported a position in Eli Lilly in Q4 2015 and held it in 5 quarters.
  • Delphi Private Advisors's Eli Lilly position peaked at $24K in Q4 2015.
  • 1,249 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2017.

Based on Delphi Private Advisors's 13F filing for Q1 2017, filed 25 Apr 2017.